anti obesity medication, diabetes, glp 1, glp 1 receptor agonist, glucagon like peptide 1, health medical pharma, in denmark, in science, michael weintraub, muscle atrophy, obesity, peptide hormones, peptide therapeutics, samuel klein, semaglutide, Tech Industry, Tech News, weight loss
The Truth About Ozempic and Muscle Loss
It’s hard to go a day without hearing something new about the latest diabetes and obesity medications, semaglutide and tirzepatide. Usually, the buzz is positive, but there has been a persistent claim made about these drugs that would make any potentia…
